KKRC
AGN

Kohlberg Kravis Roberts & Co’s Allergan plc AGN Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-16,500
Closed -$3.8M – 61
2016
Q3 		$3.8M Buy
+16,500
New +$4.03M 0.05% 42
2016
Q1 		– Sell
-42,300
Closed -$12.1M – 61
2015
Q4 		$13.2M Hold
42,300
– – 0.13% 27
2015
Q3 		$11.5M Buy
42,300
+9,476
+29% +$2.91M 0.12% 27
2015
Q2 		$9.96M Buy
32,824
+11,324
+53% +$3.38M 0.09% 30
2015
Q1 		$6.4M Buy
+21,500
New +$6.13M 0.07% 44

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Kohlberg Kravis Roberts & Co's AGN Position: Q4 2016 in Review

Kohlberg Kravis Roberts & Co sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 16,500 shares — an estimated $3.8M sold.

Kohlberg Kravis Roberts & Co first reported a position in AGN in Q1 2015 and held it in 5 quarters. The position peaked at $13.2M in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Kohlberg Kravis Roberts & Co reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 16,500 Allergan plc shares in Q4 2016, an estimated $3.8M.
  • Kohlberg Kravis Roberts & Co first reported a position in Allergan plc in Q1 2015 and held it in 5 quarters.
  • Kohlberg Kravis Roberts & Co's Allergan plc position peaked at $13.2M in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q4 2016, filed 14 Feb 2017.